Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma

Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.

183 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma trial results

Recruiting

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

NCT06840834

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Besançon - CHU Besançon, France
  • Brest - CHU Brest, France
  • Caen - CHU Caen, France
  • Clermont-Ferrand - Centre Jean Perrin Clermont-Ferrand, France
View all 21 locations
View Trial Details
Recruiting

SW-682 in Advanced Solid Tumors

NCT06251310

Conditions
Adenoma, Advanced Solid Tumor, Lung Diseases, +12 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UC San Diego Moores Cancer Center Sacramento, California, United States
  • UCLA Hematology-Oncology - Santa Monica Santa Monica, California, United States
View Trial Details
Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

NCT05568680

Conditions
Adenoma, Adnexal Diseases, Cholangiocarcinoma Recurrent, +26 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions